Clinical Trial Update: Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive [Phase 1]

View source ↗

Summary

Phase 1 safety study of the Modified Vaccinia Ankara (MVA) smallpox vaccine in HIV-positive, vaccinia-naive individuals; the trial sponsored by Sanofi Pasteur w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Smallpox

Drugs mentioned

• MVA Smallpox Vaccine (Modified vaccinia Ankara smallpox vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: HIV Infections, Smallpox | Phase 1 | Status: TERMINATED